Search
Close this search box.
Search
Close this search box.

Cyprus Prioritizes Security of Medicine Supply at EU Health Council Meeting

Brussels: Cyprus Minister of Health, Michalis Damianos, participated in the EU Health Council (EPSCO) meeting in Brussels, focusing on the Regulation on critical medicines. Damianos emphasized Cyprus’s commitment to strengthening the EU’s supply security and ensuring equitable access to medicines for all patients.

According to Cyprus News Agency, the Minister expressed gratitude to the Danish Presidency for its efforts over the past six months. He mentioned that during the upcoming Cypriot Presidency, they would build on the momentum created to finalize the remaining legislative packages.

Damianos highlighted the importance of coordination and strategy, especially in light of the COVID-19 pandemic, which proved that significant achievements are possible. He reiterated that the ultimate goal is to ensure health equity across the European Union.

During the session, the ministers of the 27 Member States endorsed the Council’s negotiating position on the Regulation concerning critical medicines. Damianos welcomed the Danish Presidency’s progress and stated Cyprus’s readiness to begin negotiations with the European Parliament to reach a political agreement.

In his official statement, Damianos expressed appreciation for the Danish Presidency’s inclusive approach that facilitated a compromise reflecting all Member States’ priorities. He assured that Cyprus is prepared to endorse the compromise texts and support the adoption of the general approach.

The Minister underscored that the Cypriot Presidency aims to strengthen the resilience of the Union’s pharmaceutical sector while considering all Member States’ needs. He also addressed concerns regarding the Wastewater Treatment Directive and the introduction of Extended Producer Responsibility (EPR) for micropollutant removal, noting the potential impact on medicine availability and affordability.

Damianos pointed out the increased risks due to current conditions, such as high production costs and stressed supply chains, which could lead to product withdrawals in small markets. He emphasized the need for an updated Commission study and proportionate EPR systems to protect both environmental objectives and the pharmaceutical supply chain’s resilience.

On the sidelines, Damianos met with Commissioner for Health and Food Safety Oliv©r V¡rhelyi, Director-General for Health and Food Safety Sandra Gallina, and German Minister of Health Nina Warken. He is also expected to meet with European Parliament’s Public Health Committee Chair Jarubas Adam Sebastian and other SANT Committee members.